CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) 1 - USD ($)	9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Operating expenses:
Research and development	$ 18,893,857	$ 17,818,373
General and administrative	8,220,768	9,902,120
Total operating expenses	27,114,625	27,720,493
Operating loss	(27,114,625)	(27,720,493)
Gain (loss) on derivative instruments	366,791	(991,562)
Other non-operating (loss) gain	(30,793)	1,428,260
Interest expense, net	(1,460,055)	(872,457)
Net loss	(28,238,682)	(28,156,252)
Modification of warrants	(294,409)	(350,861)
Net loss available to common shareholders	$ (28,533,091)	$ (28,507,113)
Net loss per common share - basic	$ (0.66)	$ (0.71)
Weighted average common shares outstanding - basic	43,124,972	39,907,624
Net loss per common share - diluted	$ (0.66)	$ (0.74)
Weighted average common shares outstanding - diluted	43,124,972	40,158,321